Topic

California

A collection of 516 issues

Humana's Coverage Criteria for Oxlumo (lumasiran) in California: What Counts as "Medically Necessary"?

Quick Answer: Humana requires prior authorization for Oxlumo (lumasiran) in California with documented PH1 diagnosis, elevated urinary oxalate levels, and nephrology specialist prescribing. Submit PA via Humana provider portal with genetic testing, baseline labs, and medical necessity letter. If denied, file internal appeal within 60 days, then California Independent Medical

How to Get Strimvelis Gene Therapy Covered by Cigna in California: Complete Forms, Appeals & Travel Guide

Answer Box: Getting Strimvelis Covered by Cigna in California Strimvelis (autologous CD34+ ADA-SCID gene therapy) requires prior authorization from Cigna and is only available at SR-TIGET in Milan, Italy. For California members, the fastest path involves: (1) Submit Cigna's California General Medication Prior Authorization Form with genetic testing

Getting Onivyde (Irinotecan Liposome) Covered by Blue Cross Blue Shield California: Formulary Alternatives & Exception Paths

Answer Box: Onivyde Coverage Through Blue Cross Blue Shield California If Onivyde (irinotecan liposome) isn't approved by Blue Cross Blue Shield California, you have three main paths: try formulary alternatives like FOLFIRINOX or gemcitabine-based regimens, request a formulary exception with clinical documentation, or appeal through California's

How to Get Revlimid (Lenalidomide) Covered by Blue Cross Blue Shield in California: Appeals, Forms & Timeline

Quick Answer: Getting Revlimid (Lenalidomide) Covered by Blue Cross Blue Shield in California Key Update: Blue Cross Blue Shield plans in California now primarily cover generic lenalidomide instead of brand-name Revlimid as of 2025. Your doctor must submit prior authorization for generic lenalidomide through the OncoHealth portal or by calling

How Long Does It Take to Get Filsuvez (Birch Triterpenes Topical Gel) Approved by Humana in California? Timeline & Appeals Guide

Answer Box: Filsuvez Approval Timeline with Humana in California Getting Filsuvez (birch triterpenes topical gel) approved by Humana typically takes 7-30 days, depending on documentation completeness and plan type. For fastest approval: (1) Confirm epidermolysis bullosa diagnosis with correct ICD-10 codes (Q81.0-Q81.9), (2) Submit prior authorization through Humana&

How to Get Sylvant (Siltuximab) Covered by Humana in California: Complete Prior Authorization Guide

Answer Box: Getting Sylvant (Siltuximab) Covered by Humana in California Sylvant (siltuximab) requires prior authorization from Humana for patients with HIV-negative and HHV-8-negative multicentric Castleman disease. The fastest path to approval: (1) Confirm your diagnosis meets FDA criteria with recent negative HIV/HHV-8 lab results, (2) Have your oncologist complete

How to Get Dupixent (dupilumab) Covered by Humana in California: Complete Appeals Guide with Forms and Scripts

Answer Box: Getting Dupixent (dupilumab) Covered by Humana in California Fastest path to approval: Humana requires prior authorization for Dupixent, with step therapy documentation often needed. Submit complete clinical documentation including diagnosis, prior treatment failures, and medical necessity letter via Humana's provider portal or fax 877-486-2621. Standard decisions

How to Get Photrexa Covered by Humana in California: Prior Authorization Guide & Appeals Process

Answer Box: Getting Photrexa Covered by Humana in California Photrexa (riboflavin ophthalmic solution) is covered by Humana Medicare Advantage plans in California, but prior authorization is required. The fastest path to approval: (1) Your eye doctor submits a PA request with progression documentation (Kmax increase ≥1.0 D or pachymetry

Renewing Gattex (Teduglutide) Approval with Aetna CVS Health in California: Documentation Timeline and Appeal Guide

Answer Box: Renewing Gattex (Teduglutide) with Aetna CVS Health in California Start 60-90 days before your current authorization expires. Submit renewal documentation showing clinical response (≥20% reduction in parenteral nutrition), required safety labs (alkaline phosphatase, amylase, lipase, bilirubin), and ongoing medical necessity. If denied, California's Independent Medical Review

UnitedHealthcare's Coverage Criteria for Elzonris (Tagraxofusp-erzs) in California: What Counts as "Medically Necessary"?

Answer Box: Getting Elzonris Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Elzonris (tagraxofusp-erzs) with strict medical necessity criteria. Key requirements include confirmed CD123-positive BPDCN diagnosis, capillary leak syndrome monitoring plan, and inpatient initiation. If denied, California's Independent Medical Review (IMR) has a 68% success rate